Elon Musk-backed biotechnology company Neuralink announced the raise of $280 million in Series D funding, led by Peter Thiel’s Founders Fund, in a short tweet on Monday.
We’re happy to announce our $280M Series D round led by @foundersfund. We’re extremely excited about this next chapter at Neuralink.
If you’d like to help make the first human experience incredible and work on engineering challenges to restore vision and mobility, come join!…
— Neuralink (@neuralink) August 7, 2023
“Excited to support Neuralink’s next chapter of helping human patients in need,” Scott Nolan, partner at Founders Fund, subsequently posted to Twitter. “The team has been working for seven years to make this possible, pulling off technical breakthroughs that feel like science fiction.”
Co-founded in 2016 by Elon Musk, Fremont, Calif.-based Neuralink develops implantable brain-computer interfaces or BCIs designed to enable direct communication between the brain and external devices like computers.
Founders Fund has
Go to Source to See Full Article
Author: Jason Nelson
Tip BTC Newswire with Cryptocurrency